noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Mammoth Energy Services Inc.

Mammoth Announces Payoff and Termination of Term Credit Facility and[...]
Conagra Brands Inc.

Swiss Miss and Hotel Tango Distillery Collaborate to Create First[...]
Thermon Group Holdings Inc.

THERMON EXPANDS ELECTRIC HEATER OFFERING THROUGH ACQUISITION OF F.A.T.I[...]

Healthcare

Avidity Biosciences Inc.

10/03/2024 | Press release | Distributed by Public on 10/03/2024 05:03

Material Event Form 8 K

Item 8.01.

Other Events.

On October 3, 2024, Avidity Biosciences, Inc. announced the U.S. Food and Drug Administration has removed the partial clinical hold related to delpacibart etedesiran.

Sharing and Personal Tools

Please select the service you want to use: